The Scientific Team at Inhalon Biopharma is responsible for researching, designing, and developing the inhaled immunotherapy platform aimed at treating a range of acute respiratory infections (ARIs). Team members, including Associate Scientists, Senior Scientists, and QA/QC specialists, collaborate to conduct experiments, analyze data, and ensure the efficacy and safety of potential treatments, ultimately advancing therapeutic solutions for ARIs like RSV, influenza, and SARS.